MAPT and Alzheimer disease: Experimental data obtained in animal models of AD suggest that low levels of testosterone increase Aβ and tau pathology through both androgen and estrogen pathways (testosterone is metabolized in the brain into androgen dihydrotestosterone, DHT, and 17β-estradiol, the E2 estrogen) [62, 63].